Page 52 - GPD-4-1

Gene & Protein in Disease GPER1 in brain and heart diseases

concentration in a rat model of chronic unpredictable mild disorder: An 8-week, randomized, double-blind, placebo-
stress. Food Funct. 2020;11(10):8780-8787. controlled study. Ther Adv Psychopharmacol. 2013;3(1):21-27.
doi: 10.1039/d0fo00524j doi: 10.1177/2045125312464103
128. Macêdo DS, Sanders LLO, das Candeias R, et al. G protein- 138. Kalpana S. Genestein, a phytoestrogens for the treatment of
coupled estrogen receptor 1 (GPER) as a novel target for schizophrenia. Int J Sci Eng Res. 2013;4:296-321.
schizophrenia drug treatment. Schizophrenia Bull Open. 139. Reddy DS, Thompson W, Calderara G. Molecular
2020;1(1):sgaa062.
mechanisms of sex differences in epilepsy and seizure
doi: 10.1093/schizbullopen/sgaa062 susceptibility in chemical, genetic and acquired
epileptogenesis. Neurosci Lett. 2021;750:135753.
129. Salehi MA, Zafari R, Mohammadi S, et al. Brain-based sex
differences in schizophrenia: A systematic review of fMRI doi: 10.1016/j.neulet.2021.135753
studies. Hum Brain Mapp. 2024;45(5):e26664.
140. Christensen J, Kjeldsen MJ, Andersen H, Friis ML,
doi: 10.1002/hbm.26664 Sidenius P. Gender differences in epilepsy. Epilepsia.
2005;46(6):956-960.
130. Hursitoglu O, Orhan F, Kurutas E, Doganer A, Durmuş H,
Bozkus O. Evaluation serum levels of G protein-coupled doi: 10.1111/j.1528-1167.2005.51204.x
estrogen receptor and its diagnostic value in patients 141. Betjemann JP, Lowenstein DH. Status epilepticus in adults.
with schizophrenia. Psychiatry Clin Psychopharmacol. Lancet Neurol. 2015;14(6):615-624.
2020;30(2):115.
doi: 10.1016/S1474-4422(15)00042-3
doi: 10.5455/PCP.20200521025152
142. Reddy DS. Brain structural and neuroendocrine basis of sex
131. Monte AS, da Silva FER, Lima CNC, et al. Sex influences in the
preventive effects of N-acetylcysteine in a two-hit animal model differences in epilepsy. Handb Clin Neurol. 2020;175:223-233.
of schizophrenia. J Psychopharmacol. 2020;34(1):125-136. doi: 10.1016/B978-0-444-64123-6.00016-3
doi: 10.1177/0269881119875979 143. Bäckström T. Epileptic seizures in women related to plasma
estrogen and progesterone during the menstrual cycle. Acta
132. da Silva FER, Cordeiro RC, de Carvalho Lima CN, et al. Neurol Scand. 1976;54(4):321-347.
Sex and the estrous-cycle phase influence the expression
of G protein-coupled estrogen receptor 1 (GPER) in doi: 10.1111/j.1600-0404.1976.tb04363.x
schizophrenia: Translational evidence for a new target. Mol 144. Logothetis J, Harner R, Morrell F, Torres F. The role of
Neurobiol. 2023;60(7):3650-3663.
estrogens in catamenial exacerbation of epilepsy. Neurology.
doi: 10.1007/s12035-023-03295-x 1959;9(5):352-360.
133. He J, Wei Y, Li J, et al. Sex differences in the association of doi: 10.1212/wnl.9.5.352
treatment-resistant schizophrenia and serum interleukin-6 145. Mastrangelo M, Torres B, de Vita G, et al. Neurodevelopmental
levels. BMC Psychiatry. 2023;23(1):470. impairment as the main phenotypic hallmark associated
doi: 10.1186/s12888-023-04952-0 with the translocation t(7;10)(7p22.3;q26.11). J Pediatr
Genet. 2022;11(1):68-73.
134. Zhang C, Liu Q, Yu CY, et al. G protein-coupled estrogen
receptor 1 knockout deteriorates MK-801-induced learning doi: 10.1055/s-0040-1715479
and memory impairment in mice. Front Behav Neurosci. 146. Zuo D, Wang F, Rong W, et al. The novel estrogen receptor
2020;14:157.
GPER1 decreases epilepsy severity and susceptivity in
doi: 10.3389/fnbeh.2020.00157 the hippocampus after status epilepticus. Neurosci Lett.
2020;728:134978.
135. Matrisciano F. Functional nutrition as integrated
intervention for in- and outpatient with schizophrenia. Curr doi: 10.1016/j.neulet.2020.134978
Neuropharmacol. 2023;21(12):2409-2423.
147. Zhang X, Yang Y, Guo L, et al. GPER1 modulates synaptic
doi: 10.2174/1570159X21666230322160259 plasticity during the development of temporal lobe epilepsy
in rats. Neurochem Res. 2021;46(8):2019-2032.
136. Munawar N, Ahsan K, Ahmad A. Natural molecules in
the treatment of schizophrenia. In: Oliveira MR, editor. doi: 10.1007/s11064-021-03336-8
Natural Molecules in Neuroprotection and Neurotoxicity. 148. Kurt AH, Bosnak M, Inan SY, Celik A, Uremis MM.
Netherlands: Elsevier; 2024. p. 259-280.
Epileptogenic effects of G protein-coupled estrogen receptor
doi: 10.1016/B978-0-443-23763-8.00011-7 1 in the rat pentylenetetrazole kindling model of epilepsy.
Pharmacol Rep. 2016;68(1):66-70.
137. Loftis JM, Wilhelm CJ, Huckans M. Effect of epigallocatechin
gallate supplementation in schizophrenia and bipolar doi: 10.1016/j.pharep.2015.07.001

Volume 4 Issue 1 (2025) 23 doi: 10.36922/gpd.4632